×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IRMD – iradimed corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IRMD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/10
07:33 am
irmd
IRADIMED CORPORATION (NASDAQ:IRMD) Passed Our Checks, And It's About To Pay A US$0.15 Dividend [Yahoo! Finance]
Low
Report
IRADIMED CORPORATION (NASDAQ:IRMD) Passed Our Checks, And It's About To Pay A US$0.15 Dividend [Yahoo! Finance]
11/4
08:30 am
irmd
IRADIMED CORPORATION Named to Fortune’s 100 Fastest Growing Companies List for 2024
Low
Report
IRADIMED CORPORATION Named to Fortune’s 100 Fastest Growing Companies List for 2024
11/3
08:04 am
irmd
Results: IRADIMED CORPORATION Exceeded Expectations And The Consensus Has Updated Its Estimates [Yahoo! Finance]
Low
Report
Results: IRADIMED CORPORATION Exceeded Expectations And The Consensus Has Updated Its Estimates [Yahoo! Finance]
10/31
09:45 pm
irmd
IRadimed (IRMD) Beats Q3 Earnings and Revenue Estimates [Yahoo! Finance Canada]
Medium
Report
IRadimed (IRMD) Beats Q3 Earnings and Revenue Estimates [Yahoo! Finance Canada]
10/31
08:00 am
irmd
IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
Medium
Report
IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
10/24
04:05 pm
irmd
IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st
Low
Report
IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st
10/7
01:11 pm
irmd
If EPS Growth Is Important To You, IRADIMED (NASDAQ:IRMD) Presents An Opportunity [Yahoo! Finance]
Low
Report
If EPS Growth Is Important To You, IRADIMED (NASDAQ:IRMD) Presents An Opportunity [Yahoo! Finance]
10/3
04:15 pm
irmd
IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference [Yahoo! Finance]
Low
Report
IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
03:36 pm
irmd
Form SC 13G/A IRADIMED CORP Filed by: Soleus Capital Master Fund, L.P.
Low
Report
Form SC 13G/A IRADIMED CORP Filed by: Soleus Capital Master Fund, L.P.
11/8
02:22 pm
irmd
Form SC 13G IRADIMED CORP Filed by: BlackRock, Inc.
Low
Report
Form SC 13G IRADIMED CORP Filed by: BlackRock, Inc.
11/6
04:15 pm
irmd
Form 4 IRADIMED CORP For: Nov 06 Filed by: VUOTO ANTHONY
Low
Report
Form 4 IRADIMED CORP For: Nov 06 Filed by: VUOTO ANTHONY
11/6
12:14 pm
irmd
Form 144 IRADIMED CORP Filed by: VUOTO ANTHONY
Low
Report
Form 144 IRADIMED CORP Filed by: VUOTO ANTHONY
10/31
04:17 pm
irmd
Form 10-Q IRADIMED CORP For: Sep 30
Medium
Report
Form 10-Q IRADIMED CORP For: Sep 30
10/31
08:00 am
irmd
Form 8-K IRADIMED CORP For: Oct 31
Medium
Report
Form 8-K IRADIMED CORP For: Oct 31
10/22
03:25 pm
irmd
Form SC 13G IRADIMED CORP Filed by: BlackRock, Inc.
Low
Report
Form SC 13G IRADIMED CORP Filed by: BlackRock, Inc.
10/15
05:45 pm
irmd
Form 4 IRADIMED CORP For: Oct 14 Filed by: Scharen-Guivel Hilda Frederique
Low
Report
Form 4 IRADIMED CORP For: Oct 14 Filed by: Scharen-Guivel Hilda Frederique
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
7/29
Form 8-K IRADIMED CORP For: Jul 29
33.3%
9/12 Form 4 IRADIMED CORP For: Sep 10 Filed by: JOHNSON BRENT 13.4%
3/24 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $18.00 price target on the stock. 12.5%
3/31 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $21.00 price target on the stock. 9.7%
12/11 Form 4 IRADIMED CORP For: Dec 09 Filed by: JOHNSON BRENT 7.7%
2/6 IRADIMED CORPORATION Announces Fourth Quarter 2019 Financial Results 7.1%
4/3 Iradimed Corp (NASDAQ: IRMD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 6.9%
10/30 Q3/2019 9/30/2019 EPS 0.230 ZacksConsensus 0.130 ActVsEst 0.100 - Beat 5.7%
4/14 Iradimed Corp (NASDAQ: IRMD) had its price target lowered by analysts at Roth Capital from $32.00 to $30.00. 5.0%
8/7 Form 4 IRADIMED CORP For: Aug 05 Filed by: JOHNSON BRENT 4.9%
9/12 Form 4 IRADIMED CORP For: Sep 10 Filed by: JOHNSON BRENT 13.4%
3/24 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $18.00 price target on the stock. 12.5%
3/31 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $21.00 price target on the stock. 9.7%
12/11 Form 4 IRADIMED CORP For: Dec 09 Filed by: JOHNSON BRENT 7.7%
2/6 IRADIMED CORPORATION Announces Fourth Quarter 2019 Financial Results 7.1%
4/3 Iradimed Corp (NASDAQ: IRMD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 6.9%
10/30 Q3/2019 9/30/2019 EPS 0.230 ZacksConsensus 0.130 ActVsEst 0.100 - Beat 5.7%
4/14 Iradimed Corp (NASDAQ: IRMD) had its price target lowered by analysts at Roth Capital from $32.00 to $30.00. 5.0%
8/7 Form 4 IRADIMED CORP For: Aug 05 Filed by: JOHNSON BRENT 4.9%
TOP News Decliners
4/30
Form 8-K IRADIMED CORP For: Apr 30
-9.0%
3/12 IRADIMED CORPORATION Announces the Appointment of Lynn Neuhardt as Vice President of Research and Development -7.8%
5/7 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $28.00 price target on the stock. -6.1%
11/1 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.8%
2/25 Form 4 IRADIMED CORP For: Feb 24 Filed by: JOHNSON BRENT -5.6%
2/28 Iradimed Corp (NASDAQ: IRMD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -5.1%
8/5 Form 4 IRADIMED CORP For: Aug 01 Filed by: Waldman Louis S. -5.1%
11/5 Form 4 IRADIMED CORP For: Nov 04 Filed by: Nardi Steven M. -4.9%
3/26 Form 4 IRADIMED CORP For: Mar 24 Filed by: JOHNSON BRENT -4.5%
3/4 Form 4 IRADIMED CORP For: Mar 02 Filed by: JOHNSON BRENT -3.9%
3/12 IRADIMED CORPORATION Announces the Appointment of Lynn Neuhardt as Vice President of Research and Development -7.8%
5/7 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $28.00 price target on the stock. -6.1%
11/1 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.8%
2/25 Form 4 IRADIMED CORP For: Feb 24 Filed by: JOHNSON BRENT -5.6%
2/28 Iradimed Corp (NASDAQ: IRMD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -5.1%
8/5 Form 4 IRADIMED CORP For: Aug 01 Filed by: Waldman Louis S. -5.1%
11/5 Form 4 IRADIMED CORP For: Nov 04 Filed by: Nardi Steven M. -4.9%
3/26 Form 4 IRADIMED CORP For: Mar 24 Filed by: JOHNSON BRENT -4.5%
3/4 Form 4 IRADIMED CORP For: Mar 02 Filed by: JOHNSON BRENT -3.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: